All posts by PIER MARIA FORNASARI

PIER MARIA FORNASARI
2026-02-10

The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process

The challenge of mitigating the growing incidence of dementia has prompted a significant collaborative effort among researchers, healthcare professionals, and policymakers. The recently published insights from the Nottingham consensus shed light on dementia risk reduction, proposing strategies that stem from a comprehensive modified Delphi process. This effort brings together multi-disciplinary insights to forge a robust

Read More

No Comments InWELLNESS
PIER MARIA FORNASARI
2026-02-08

Study suggests Fibronectin, a protein made in the liver, is a key factor in men’s bone health

This is another example of how diseases can develop differently between the sexes, professor says, highlighting the value of sex-specific research. New research suggests the liver plays a previously unrecognized role in bone health, but only in males. A McGill University-led study published in Matrix Biology found that a protein made in the liver helps regulate bone

Read More

No Comments InWELLNESS
PIER MARIA FORNASARI
2026-02-05

AI-enabled stethoscope demonstrated to be twice as efficient at detecting valvular heart disease in the clinic

Key takeaways New research shows that the use of an AI-enabled digital stethoscope more than doubled the identification of moderate to severe valvular heart disease during routine clinical examinations, compared to a traditional stethoscope.  The US study, ‘Artificial-Intelligence-Enabled Digital Stethoscope Improves Point-of-Care Screening for Moderate to Severe Valvular Heart Disease’, was published today (Thursday 5

Read More

No Comments InWELLNESS
PIER MARIA FORNASARI
2026-02-04

Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch

Research from Amsterdam UMC, in collaboration with Cardiology Centers Netherlands, shows that smartwatches equipped with heart monitoring functions can play a role in detecting cardiac arrhythmias. Analysis of data from 437 high-risk patients showed that cardiac arrhythmias were detected four times more often in those wearing a smartwatch. The results are published in JACC journal

Read More

No Comments InWELLNESS
PIER MARIA FORNASARI
2026-01-26

A simple blood test can predict Crohn’s disease before symptoms appear

Sinai Health researchers have shown a blood test can predict Crohn’s disease years before symptoms appear, opening the doors to early diagnosis and potentially prevention. The test measures a person’s immune response to flagellin, a protein found on gut bacteria. This response is elevated in individuals long before they develop Crohn’s Disease, a team led

Read More

No Comments InRESEARCH WELLNESS
PIER MARIA FORNASARI
2026-01-25

ISSCR Develops Roadmap to Accelerate Pluripotent Stem Cell-Derived Therapies to Patients

“Charting the Translational Pathway: ISSCR Best Practices for the Development of PSC-Derived Therapies,” offers insights into the comprehensive, globally informed guide to navigating the complex journey from laboratory discovery to approved therapy. The International Society for Stem Cell Research (ISSCR) today announced the upcoming release of “Charting the Translational Pathway: ISSCR Best Practices for the

Read More

No Comments InCELL THERAPY
PIER MARIA FORNASARI
2026-01-25

New Study Sheds Light on Stroke Recovery via Exercise-Induced Migration of Mitochondria

Researchers show how exercise protects the brain against stroke by inducing migration of tiny powerhouses through the bloodstream. While thrombolytic therapy remains one of the most effective strategies for stroke recovery, it is effective only for a short span of time. Now, researchers from Japan have demonstrated how numerous mitochondria, the powerhouses of the cell,

Read More

No Comments InRESEARCH WELLNESS
PIER MARIA FORNASARI
2026-01-17

When a virus releases the immune brake: New evidence on the onset of multiple sclerosis

Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of them, it remains unclear why this process begins. Researchers have now identified how the Epstein-Barr virus can, under specific conditions, initiate early multiple sclerosis-like damage in the brain. This offers a new perspective on how

Read More

No Comments InRESEARCH
PIER MARIA FORNASARI
2026-01-17

First-in-human new liver- and gut-targeted oral drug trial lowers high blood fats

In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug can safely lower triglycerides and other blood lipids. When we eat, our bodies convert extra calories, especially from carbs, sugar, fats, and alcohol, into molecules called “triglycerides”. Triglycerides are a form of fat

Read More

No Comments InCLINICAL TRIALS